Study S001957

A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practice in Germany Non-interventional.

ClinicalTrials.gov record

Registration

Registration: NCT07081178
Acronym: WeGoReal
Study type: OBSERVATIONAL
Status: TERMINATED
Enrollment: 100
Start: 2025-08-08
Primary completion: 2025-12-18
Lead sponsor: Novo Nordisk A/S
Conditions: Obesity
Interventions: DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1314-8335

Registered primary outcomes

Change in relative body weight [From baseline to month 6 and month 9]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.